SMARCA4 and Salla disease: This finding underscores the importance of considering SMARCA4 immunohistochemistry when evaluating undifferentiated cutaneous tumors, as well as performing comprehensive systemic staging when a primary cutaneous SD‐UMN is diagnosed.